Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? Case report and review of the literature.
Vitamin D3 influence the Th1/Th2 ratio in C57BL/6 induced model of experimental autoimmune encephalomyelitis.
A New Zealand pilot randomized controlled trial of a web-based interactive self-management programme (MSInvigor8) with and without email support for the treatment of multiple sclerosis fatigue.
Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis.
Identifying the amylome, proteins capable of forming amyloid-like fibrils.
Serum exosomes in pregnancy-associated immune modulation and neuroprotection during CNS autoimmunity.
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training.
High-resolution melting analysis for mutation scanning in the non-coding control region of JC polyomavirus from patients with progressive multifocal leukoencephalopathy.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Multiple sclerosis update.
CBRAIN: a web-based, distributed computing platform for collaborative neuroimaging research.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Examining the factor structure of the multiple sclerosis impact scale.
Subcutaneous Interferon β-1a May Protect against Cognitive Impairment in Patients with Relapsing-Remitting Multiple Sclerosis: 5-Year Follow-up of the COGIMUS Study.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Commentary on neuromyelitis optica associated with painful paroxysmal dystonia: case report and literature review.
MicroRNA in neurodegenerative drug discovery: the way forward?
Managing patients with neurologic disorders who participate in sports activities.
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature.
Learning a cost function for microscope image segmentation.
Co-existence of tumefactive MS and hepatitis C: A need for further screening and new therapeutic challenge.
Cardiorespiratory fitness and its association with thalamic, hippocampal, and basal ganglia volumes in multiple sclerosis.
Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis.

Pages